Jacqui Frowen1, Rhys Hughes2, Jemma Skeat3. 1. Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria, 8006, Australia. Jacqui.Frowen@petermac.org. 2. Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria, 8006, Australia. 3. Department of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
Abstract
PURPOSE: Research investigating swallowing problems (dysphagia) and complications within the oral cavity in non-head and neck cancer patients is limited. The purpose of this study was to determine the prevalence of patient-reported dysphagia and oral complications in all cancer patients and to examine the relationships between cancer types, oral complications and dysphagia. METHODS: A cross-sectional study was conducted at a specialist cancer centre in Australia. Data on patient-reported dysphagia and oral complications were collected using the Vanderbilt Head and Neck Symptom Survey (version 2.0) which was completed by participants in one of three settings: inpatients, ambulatory patients receiving chemotherapy, or ambulatory patients receiving radiotherapy. RESULTS: Data were collected on 239 patients, receiving treatment for 14 cancer types. The proportion of patients who reported dysphagic symptoms were as follows: any dysphagia (54%); dysphagia for liquids (20%); and dysphagia for solids (46%). Significantly more head and neck patients and significantly fewer breast patients reported dysphagia, but there were no differences between other tumour types. Oral symptoms across all cancer types were reported at the following rates: taste changes (62%); xerostomia (56%); voice changes (37%); smell changes (35%); thick mucous (33%); difficulty with teeth/dentures (25%); mouth/throat pain (20%); and trismus (19%). CONCLUSIONS: This is the first time comprehensive data on dysphagia and oral complications across all cancer patients have been collected. We have identified that dysphagic symptoms and oral complications-which have implications for quality of life and function-are common in all cancer patients, not just those with head and neck cancer.
PURPOSE: Research investigating swallowing problems (dysphagia) and complications within the oral cavity in non-head and neck cancerpatients is limited. The purpose of this study was to determine the prevalence of patient-reported dysphagia and oral complications in all cancerpatients and to examine the relationships between cancer types, oral complications and dysphagia. METHODS: A cross-sectional study was conducted at a specialist cancer centre in Australia. Data on patient-reported dysphagia and oral complications were collected using the Vanderbilt Head and Neck Symptom Survey (version 2.0) which was completed by participants in one of three settings: inpatients, ambulatory patients receiving chemotherapy, or ambulatory patients receiving radiotherapy. RESULTS: Data were collected on 239 patients, receiving treatment for 14 cancer types. The proportion of patients who reported dysphagic symptoms were as follows: any dysphagia (54%); dysphagia for liquids (20%); and dysphagia for solids (46%). Significantly more head and neck patients and significantly fewer breast patients reported dysphagia, but there were no differences between other tumour types. Oral symptoms across all cancer types were reported at the following rates: taste changes (62%); xerostomia (56%); voice changes (37%); smell changes (35%); thick mucous (33%); difficulty with teeth/dentures (25%); mouth/throat pain (20%); and trismus (19%). CONCLUSIONS: This is the first time comprehensive data on dysphagia and oral complications across all cancerpatients have been collected. We have identified that dysphagic symptoms and oral complications-which have implications for quality of life and function-are common in all cancerpatients, not just those with head and neck cancer.
Entities:
Keywords:
Cancer therapies; Deglutition; Oral complications; Quality of life; Swallowing
Authors: Emily Cooperstein; Jill Gilbert; Joel B Epstein; Mary S Dietrich; Stewart M Bond; Sheila H Ridner; Nancy Wells; Anthony Cmelak; Barbara A Murphy Journal: Head Neck Date: 2011-08-24 Impact factor: 3.147
Authors: Rene-Jean Bensadoun; Dorothea Riesenbeck; Peter B Lockhart; Linda S Elting; Fred K L Spijkervet; Mike T Brennan Journal: Support Care Cancer Date: 2010-03-06 Impact factor: 3.603
Authors: D De Ruysscher; C Dehing; R-H Bremer; S M Bentzen; F Koppe; M Pijls-Johannesma; L Harzée; A Minken; R Wanders; M Hochstenbag; A-M Dingemans; L Boersma; E van Haren; W Geraedts; C Pitz; J Simons; Bg Wouters; J-F Rosier; P Lambin Journal: Ann Oncol Date: 2007-02-23 Impact factor: 32.976
Authors: Jip M van Elst; Nikki S IJzerman; Ron H J Mathijssen; Neeltje Steeghs; Anna K L Reyners; Jacco J de Haan Journal: Support Care Cancer Date: 2021-11-02 Impact factor: 3.603
Authors: Ana Sofia Spencer; David da Silva Dias; Manuel Luís Capelas; Francisco Pimentel; Teresa Santos; Pedro Miguel Neves; Antti Mäkitie; Paula Ravasco Journal: Front Oncol Date: 2021-11-22 Impact factor: 6.244
Authors: Maria Giulia Cristofaro; Ida Barca; Francesco Ferragina; Daniela Novembre; Yvelise Ferro; Roberta Pujia; Tiziana Montalcini Journal: J Transl Med Date: 2021-11-22 Impact factor: 5.531
Authors: Sara Hadzibegovic; Philipp Sikorski; Sophia K Potthoff; Jochen Springer; Alessia Lena; Markus S Anker Journal: ESC Heart Fail Date: 2020-10-04